$AZR

Azora Therapeutics, Inc. (DE)

Nasdaq · Pharmaceutical Preparations · Encino, CA

AZR chart

What traders are saying about $AZR

Latest posts

Azora Therapeutics, Inc. (DE) news

Azora Therapeutics, Inc. (DE) key financials

USD2025202420232022
Net income-$7.98T-$13.20T-$5.12T-$12.7M
Diluted EPS$-11.93$-68.01$-3.60$-12.71
Total assets (year end)$6.7M$5.0M$4.7M$5.7M
Cash and equivalents (year end)$5.9M$3.8M$2.8M$4.0M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Azora Therapeutics, Inc. (DE)

Ticker
AZR (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Encino, CA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1513525
Former names
ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.

Frequently asked questions

What exchange is Azora Therapeutics, Inc. (DE) listed on?

Azora Therapeutics, Inc. (DE) trades on the Nasdaq under the ticker symbol AZR.

What industry is Azora Therapeutics, Inc. (DE) in?

Azora Therapeutics, Inc. (DE) is classified by the SEC under "Pharmaceutical Preparations".

Where is Azora Therapeutics, Inc. (DE) headquartered?

Azora Therapeutics, Inc. (DE)'s business address on file with the SEC is in Encino, CA.

When does Azora Therapeutics, Inc. (DE)'s fiscal year end?

Azora Therapeutics, Inc. (DE)'s fiscal year ends on December 31.